Setting product quality standards as the guiding principle for all operations, TV TPI recently organized an intensive training course on evaluating API sources and establishing raw material quality dossiers in compliance with current regulations. The training class was attended by core personnel from the OHI Institute and Reiwapharm Pharmaceutical Factory to standardize control capabilities and guarantee quality safety starting right from incoming raw materials.
The Strategic Importance of Selecting Reputable API Sources in Pharmaceutical Manufacturing
In the pharmaceutical supply and manufacturing chain, the quality of finished drug products is shaped right from the input material selection phase, particularly the active pharmaceutical ingredient (API) sources. A compliant API source is not only a core element determining therapeutic efficacy and product safety for patients, but also a benchmark confirming the brand’s solid reputation in the market. Conversely, errors or risks arising from low-quality raw material sources can lead to serious consequences during manufacturing and testing processes.
Therefore, for TV TPI, proactively enhancing capabilities to evaluate and control reputable API sources is the ultimate strategic step to ensure that output product lines consistently meet the most stringent standards of the international medical and pharmaceutical industry.
Training Core Personnel Under the Guidance of a Leading Expert
TV TPI was once again honored to welcome the mentorship of Prof. Dr. Nguyen Duc Tuan – Vice Dean of the Faculty of Pharmacy, Head of the Department of Analytical Chemistry & Quality Control at the University of Medicine and Pharmacy, Ho Chi Minh City. Through highly practical teaching methods, Prof. Dr. Nguyen Duc Tuan helped trainees master the comprehensive raw material evaluation process across key areas:
- Supplier Selection Criteria: Enhancing screening skills and evaluating reputable partners.
- Drug Master File (DMF) Analysis: Guiding deep technical dossier evaluation to ensure the quality and legal compliance of raw materials.
- Risk Assessment and Influencing Factors: Identifying and controlling factors that could impact final product quality.
In particular, to reinforce theoretical concepts, participating personnel directly practiced solving real-world case studies. This direct interaction not only enabled personnel from the OHI Institute and Reiwapharm Pharmaceutical Factory to sharpen their critical thinking, but also trained their problem-solving skills in a professional manner—preparing them to master the quality control process right at its origin.
At TV TPI, professional enhancement courses are held regularly to assist personnel in promptly catching up with the latest updated knowledge and standards in the pharmaceutical industry. Persistent investment in human capital has been building strong internal strength, driving breakthrough growth and sustainable development for the entire company on its journey to conquer upcoming strategic goals.
